in vivo Reprogramming of NG2 Glia Improves Bladder Function After Spinal Cord Injury

Area of Science:

• Neuroscience
• Regenerative Medicine
• Urology

Background:

• Neurogenic bladder is a severe condition following spinal cord injury (SCI).
• Current treatments for neurogenic bladder are limited and often fail to restore voluntary voiding.
• Spinal cord injury leads to glial scarring, hindering neural repair and function.

Purpose of the Study:

• To investigate the therapeutic potential of SOX2-mediated in vivo reprogramming of NG2 glia in a mouse model of SCI.
• To assess the impact of glial reprogramming on bladder function and underlying cellular mechanisms.

Main Methods:

• Utilized a clinically relevant mouse model of contusive spinal cord injury.
• Employed SOX2-mediated in vivo reprogramming of NG2 glia.
• Evaluated bladder function using voiding assays and conscious cystometry.
• Assessed neurogenesis and glial scarring.

Main Results:

• SOX2-mediated reprogramming of NG2 glia significantly improved bladder function in SCI mice.
• Reprogramming induced adult neurogenesis and reduced glial scarring.
• Functional recovery correlated positively with increased neurogenesis and negatively with glial scarring.

Conclusions:

• SOX2-mediated glial reprogramming is a promising regenerative strategy for neurogenic bladder.
• This approach promotes autonomic repair following spinal cord injury.
• Targeting NG2 glia offers a novel therapeutic avenue for SCI-induced bladder dysfunction.